Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HIV-NAT 079: Kaletra Monotherapy vs. Combination Therapy in NNRTI-Failing Patients
NCT00627055Phase 4Completed
- Sponsor
- HIV-NAT
- Start
- May 2008
- Primary completion
- Nov 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of lopinavir + ritonavir in human immunodeficiency virus infection (HIV), sponsored by HIV-NAT. Started May 2008; status: completed.
02
Drugs
lopinavir + ritonavir
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT00627055.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00627055.